Clik here to view.
TouchPoint Medical and PilotFish Deliver Best-Practice Mobile Medication...
OLDSMAR, Fla. TouchPoint Medical (TouchPoint), a leading global provider of innovative and intelligent hardware and software solutions for healthcare, announced today that TouchPoint’s solutions...
View ArticleClik here to view.
Tilray Announces Medical Cannabis Export to New Zealand
NANAIMO, British Columbia Tilray, a global leader in medical cannabis research and production, today announced that it has received necessary approvals in Canada and New Zealand to export medical...
View ArticleClik here to view.
Promega Corporation Brings High-Performance DNA Analysis to the Benchtop with...
MADISON, Wis. Soon scientists will be able to perform efficient DNA analysis right at their bench. Promega Corporation has announced the development of a benchtop capillary electrophoresis (CE)...
View ArticleClik here to view.
Go!Foton, Inc. Announces Joint Team Develops Rapid Mobile DNA Testing Equipment
TOKYO As part of JST Development of Advanced Measurement and Analysis Systems Program, a joint development team of Nippon Sheet Glass Co., Ltd. (NSG), National Institute of Advanced Industrial...
View ArticleClik here to view.
Median Technologies to Attend the Annual Meeting of the Asian Pacific...
SOPHIA ANTIPOLIS, France Regulatory News: Median Technologies (Paris:ALMDT), the Imaging Phenomics™ Company, announced today that it will participate in the Annual Meeting of the Asian Pacific...
View ArticleClik here to view.
Older Family Members Find Immune System Support from Mannatech’s Ambrotose®...
GUANGZHOU, China Mannatech®, a global health and wellness company, provides a powerful nutritional supplement in its Ambrotose powders that offers a perfect solution for older family members who are...
View ArticleClik here to view.
Replicorが最新のREP 401臨床データをAPASL 2017で発表
モントリオール （ビジネスワイヤ） — 慢性B型肝炎／D型肝炎の患者向け治療薬に絞った開発に取り組む非公開バイオ製薬企業のReplicor Inc.は本日、直近のREP 401臨床試験から得た最新の中間解析の結果が、中国の上海で2017年2月15～19日に開催されるアジア太平洋肝臓病学会議（APASL）年次総会の口頭発表の演題として選出されたと発表しました。 REP...
View ArticleClik here to view.
Boehringer Ingelheim and Weill Cornell Medicine announce new collaboration to...
INGELHEIM, Germany Boehringer Ingelheim today announced a collaboration with Weill Cornell Medicine to identify new treatment approaches for chronic obstructive pulmonary disease (COPD) in order to...
View ArticleClik here to view.
美商寰泰的Ambrotose®粉剂为老龄家庭成员提供免疫系统支持
中国广州 (美国商业资讯)–全球性健康和保健公司美商寰泰(Mannatech®)在其Ambrotose粉剂中提供了一种强大的营养补充成分，该粉剂为寻求增强健康免疫系统的老龄家庭成员提供了完美的解决方案。 随着年龄增长，免疫系统的关键要素可能减弱，从而对个体的整体健康和保健产生不利影响。美商寰泰的Ambrotose能够帮助支持健康的免疫系统，帮助免疫系统随时间推移而保持强健。...
View ArticleClik here to view.
NICEのガイダンスは患者の安定胸痛の原因判定に役立てるようHeartFlow FFRct Analysisを推奨
米カリフォルニア州レッドウッドシティー （ビジネスワイヤ） — 英国立医療技術評価機構（NICE）は本日、患者の安定胸痛の原因判定に役立てるよう、HeartFlow® FFRct Analysis使用のガイダンスを発出しました。ハートフローが開発したHeartFlow FFRct...
View ArticleClik here to view.
Corindus Vascular Robotics Announces Strategic Distribution Partnership with...
WALTHAM, Mass. Corindus Vascular Robotics, Inc. (NYSE MKT:CVRS), a leading developer of precision vascular robotics, announced today the recent signing of a strategic distribution agreement with...
View ArticleClik here to view.
EndoBarrier® Study in Morbidly Obese Adolescents Completes Enrollment
BOSTON & SYDNEY GI Dynamics, Inc. (ASX:GID), a medical device company that has commercialized EndoBarrier in Europe for patients with type 2 diabetes and obesity, today announced that enrollment...
View ArticleClik here to view.
Solasia and Lee’s Pharma Announce License, Promotion and Supply Agreement...
TOKYO & HONG KONG Solasia Pharma K.K. (Headquarters: Tokyo, Japan, President: Yoshihiro Arai, hereinafter “Solasia”) and Lee’s Pharmaceutical Holdings Limited (hereinafter “Lee’s Pharma”)(SEHK...
View ArticleClik here to view.
Takeda Completes Acquisition of ARIAD Pharmaceuticals, Inc.
CAMBRIDGE, Mass. & OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE:4502) (“Takeda”) today announced the completion of its acquisition of ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA)...
View ArticleClik here to view.
由 Leman Micro Devices 开发、全球首款集成于智能手机之中、可实现医学上测量准确性的健康监测系统 现已准备提交 FDA 批准
瑞士洛桑市 Leman Micro Devices (LMD) 是一家已获认可的消费性医疗保健产品开发公司，由移动设备行业的领先企业提供支持。该公司已宣布其开发的“健康传感器及 App”——唯一一个能够测量血压和其他生命体征、实现医学上测量准确性、集成于智能手机之中的解决方案——正准备提交 FDA 和其他监管机构批准。 Smart News...
View ArticleClik here to view.
Masimo宣布其MightySat™ Rx测量呼吸率获得CE标记
瑞士纳沙泰尔 (美国商业资讯) — Masimo (NASDAQ: MASI)今天宣布，根据MightySat™ Rx指尖脉搏氧饱和度仪上的血氧容积描记波(RRpTM)测量呼吸率已获得CE标记。MightySat Rx是一款无创仪器，可测量和显示功能性氧饱和度(SpO2)、脉率(PR)和灌注指数(PI)，可添加脉搏灌注变异指数(PVi®)选项，现在可添加RRp选项。 Smart News...
View ArticleClik here to view.
Takeda and TiGenix Report New Data Highlighting Maintenance of Long-Term...
OSAKA, Japan & LEUVEN, Belgium Takeda Pharmaceutical Company Limited (TSE:4502) (“Takeda”) and TiGenix NV (Euronext Brussels and Nasdaq:TIG) (“TiGenix”) today announced new data from the Phase 3...
View ArticleClik here to view.
Health Canada Approves Otsuka and Lundbeck’s REXULTI™ (brexpiprazole) as a...
TOKYO & MONTREAL Otsuka Pharmaceutical Co., Ltd. (Otsuka) and Lundbeck Canada announce that Health Canada issued a Notice of Compliance for REXULTI™ (brexpiprazole) for the treatment of...
View ArticleClik here to view.
ミネルヴァ・バイオテクノロジーズがナイーブ型幹細胞培養システムのAlphaSTEM™を発売
米マサチューセッツ州ウォルサム （ビジネスワイヤ） — がん治療および再生医療の分野における一流企業のミネルヴァ・バイオテクノロジーズは本日、AlphaSTEM™培養システムの市場投入を発表しました。このシステムは、胚形成の最初期に内部細胞塊のナイーブ細胞内のみで発現する新発見の成長因子を使用しています。...
View ArticleClik here to view.
マシモ、MightySat™ Rxによる呼吸数測定でCEマークを取得と発表
スイス・ヌーシャテル （ビジネスワイヤ） — マシモ（NASDAQ: MASI）は本日、フィンガーチップパルスオキシメーターMightySat™ Rxで脈波からの呼吸数（RRpTM）を測定する機能がCEマークを取得したと発表しました。MightySat...
View Article